Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyu-Pyo Kim

Showing results (31-40 of 217) with videos related to

Pageof 22
Sort By:
Hepatology International|January 12, 2024
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinomaHyung-Don Kim, Young-Gyu Park, Sejin Kim, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 22, 2017
Simultaneous quantitation of abiraterone, enzalutamide, N-desmethyl enzalutamide, and bicalutamide in human plasma by LC-MS/MSKyu-Pyo Kim, Robert A Parise, Julianne L Holleran, et al.
Pancreas|April 19, 2014
Primary mesenchymal tumors of the pancreas: single-center experience over 16 yearsJoo Young Kim, Joon Seon Song, Hosub Park, et al.
Targeted Oncology|November 29, 2021
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological MalignanciesToshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin, et al.
Oncology|November 28, 2014
A phase I study of UGT1A1 *28/*6 genotype-directed dosing of irinotecan (CPT-11) in Korean patients with metastatic colorectal cancer receiving FOLFIRIKyu-Pyo Kim, Yong Sang Hong, Jae-Lyun Lee, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 14, 2018
Increased incidence of chemoport-related thrombosis in patients with colorectal cancer receiving bevacizumab: A single-institutional experienceJwa Hoon Kim, Jeong Eun Kim, Yong Sang Hong, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 20, 2012
Pharmacokinetics of a fixed-dose glimepiride/sustained-release metformin combinationKyu-Pyo Kim, Kyoung Soo Lim, Bo-Hyung Kim, et al.
Clinical Therapeutics|August 22, 2009
Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in KoreaBo-Hyung Kim, SoJeong Yi, JaeWoo Kim, et al.
Drug Delivery|September 7, 2022
Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal modelsHo Yong Kim, Hyun-Ki Min, Hyeong-Woo Song, et al.
Clinical Therapeutics|February 23, 2010
Pharmacodynamic (hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studiesBo-Hyung Kim, Jung-Ryul Kim, Min-Gul Kim, et al.
Pageof 22

Showing results (31-40 of 217) with videos related to

Sort By:
Pageof 22
Hepatology International|January 12, 2024
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinomaHyung-Don Kim, Young-Gyu Park, Sejin Kim, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 22, 2017
Simultaneous quantitation of abiraterone, enzalutamide, N-desmethyl enzalutamide, and bicalutamide in human plasma by LC-MS/MSKyu-Pyo Kim, Robert A Parise, Julianne L Holleran, et al.
Pancreas|April 19, 2014
Primary mesenchymal tumors of the pancreas: single-center experience over 16 yearsJoo Young Kim, Joon Seon Song, Hosub Park, et al.
Targeted Oncology|November 29, 2021
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological MalignanciesToshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin, et al.
Oncology|November 28, 2014
A phase I study of UGT1A1 *28/*6 genotype-directed dosing of irinotecan (CPT-11) in Korean patients with metastatic colorectal cancer receiving FOLFIRIKyu-Pyo Kim, Yong Sang Hong, Jae-Lyun Lee, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 14, 2018
Increased incidence of chemoport-related thrombosis in patients with colorectal cancer receiving bevacizumab: A single-institutional experienceJwa Hoon Kim, Jeong Eun Kim, Yong Sang Hong, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 20, 2012
Pharmacokinetics of a fixed-dose glimepiride/sustained-release metformin combinationKyu-Pyo Kim, Kyoung Soo Lim, Bo-Hyung Kim, et al.
Clinical Therapeutics|August 22, 2009
Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in KoreaBo-Hyung Kim, SoJeong Yi, JaeWoo Kim, et al.
Drug Delivery|September 7, 2022
Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal modelsHo Yong Kim, Hyun-Ki Min, Hyeong-Woo Song, et al.
Clinical Therapeutics|February 23, 2010
Pharmacodynamic (hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studiesBo-Hyung Kim, Jung-Ryul Kim, Min-Gul Kim, et al.
Pageof 22